Trial Details

Authorised
Basic Information
Clinical ID c2947
Identifier EUCTR2016-000205-36-DE
Trial Title A Single-Centre, Exploratory Trial to Assess the Mechanisms of Molecular Activity, Safety and Tolerability of One Dose Level of FE 999301 by Intravenous Infusions in Patients with Active Inflammatory Bowel Disease (IBD) - FUTURE
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Inflammatory Bowel Disease (Crohn`s Disease and Ulcerative Colitis) MedDRA version: 19.0_Level: PT_Classification code 10009900_Term: Colitis ulcerative_System Organ Class: 10017947 - Gastrointestinal disorders_ MedDRA version: 19.0_Level: PT_Classification code 10011401_Term: Crohn's disease_System Organ Class: 10017947 - Gastrointestinal disorders_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Product Code: FE 999301 Pharmaceutical Form: Concentrate for solution for infusion
Participant Information
Sponsor University Hospital Schleswig-Holstein (UKSH)
City -
Country/Region Germany
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE2
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -